Evelo Biosciences Inc (EVLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2006 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 38,246 | 15,536 | N/A |
| TOTAL | $38,777 | $15,720 | $N/A |
| Non-Current Assets | |||
| PPE Net | 3,496 | 2,504 | N/A |
| Other Non-Current Assets | 1,515 | 346 | 0 |
| TOTAL | $5,011 | $2,850 | $N/A |
| Total Assets | $43,788 | $18,570 | $N/A |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 1,411 | 1,637 | 0 |
| Accrued Expenses | 2,199 | 441 | N/A |
| Other current liabilities | 229 | 170 | N/A |
| TOTAL | $3,839 | $2,248 | $N/A |
| Non-Current Liabilities | |||
| Long Term Debt | 9,966 | 9,931 | N/A |
| Other Non-Current Liabilities | 526 | 281 | 0 |
| TOTAL | $10,970 | $10,796 | $N/A |
| Total Liabilities | $14,809 | $13,044 | $N/A |
| Shareholders' Equity | |||
| Common Shares | 4 | 4 | N/A |
| Retained earnings | -56,411 | -28,341 | N/A |
| Other shareholders' equity | 83,702 | 33,863 | 0 |
| TOTAL | $28,979 | $5,526 | $N/A |
| Total Liabilities And Equity | $43,788 | $18,570 | $0 |